PCN5 COMPARING THE COST-EFFECTIVENESS OF FRONT-LOADED DARBEPOETIN ALFA WITH EPOETIN ALFA FOR ANEMIA MANAGEMENT IN CHEMOTHERAPY-TREATED CANCER PATIENTS IN UNITED STATES
Nov 1, 2002, 00:00 AM
10.1016/S1098-3015(10)61421-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)61421-0/fulltext
Section Title :
Section Order :
229
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61421-0&doi=10.1016/S1098-3015(10)61421-0